TABLE 4.
Adverse event | RASf | IVASf | Total |
---|---|---|---|
Electrolyte changes | 15 | 16 | 31 |
WBC/platelet changes | 2 | 5 | 7 |
Expelled artesunate suppositorya | 5 | 5 | 10 |
Pruritus/cutaneous rasha,b | 0 | 1 | 1 |
Urticariac | 0 | 1 | 1 |
Viral/bacterial infection suspected | 2 | 5 | 7 |
Intestinal parasite infection suspected | 1 | 1 | 2 |
Vomit | 0 | 1 | 1 |
Epistaxis | 0 | 1 | 1 |
Swollen face/acute renal failure | 0 | 1 | 1 |
Hypersialosis/acute renal failure | 0 | 1 | 1 |
Conjunctivitis (day 14) | 1 | 0 | 1 |
Gastroenteritis (day 14) | 1 | 0 | 1 |
Classified as possibly related.
Developed after i.v. artesunate administration.
Developed 8 min after blood transfusion started.